Videos

WuXi AppTec’s Felix Hsu on ‘Make vs Buy’ Decisions

The SVP and global head of advanced therapies also talks about cell and gene therapy market trends

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

At BIO 2019 Contract Pharma had a chance to talk with WuXi AppTecc’s Felix Hsu, SVP and global head of advanced therapies, about “Make vs Buy” decisions as well as cell and gene therapy market trends.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters